| Product Name | MF | CAS | Details |
|---|
| Galidesivir triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
| 2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)riboside | C14H17N5O6 | 2389988-74-1 | Details |
| TRV-120027 acetate (1234510-46-3 free base) | C45H71N13O12 | 1824712-70-0 | Details |
| Cdc7-IN-4 | C22H24F3N5O4 | 1402059-21-5 | Details |
| Cdc7-IN-3 | C20H22N4O5 | 1402057-87-7 | Details |
| BSc5371 | C24H31N5O4S | 2286419-03-0 | Details |
| BY27 | C22H21ClN6 | 2247236-59-3 | Details |
| BMT-124110 | C21H27N3O3 | 1679371-59-5 | Details |
| DC4SMe | C35H31ClN5O7PS2 | 615538-47-1 | Details |
| D-Cl-amidine | C14H19ClN4O2 | 1404060-15-6 | Details |
| CYT-1010 hydrochloride | C35H41ClN6O5 | 1161517-81-2 | Details |
| BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
| AR453588 hydrochloride | C25H26ClN7O2S2 | 1065606-97-4 | Details |
| 1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-(2-methoxy ethyl)-β-D-ribo-hex-5-enofuranosyl]-5-methyluracil | C18H29N2O9P | 1345562-43-7 | Details |
| c-Fms-IN-7 | C26H24N6OS | 1313408-89-7 | Details |
| 2’-O-Phthalimidopropyl uridine | C20H21N3O8 | 165381-44-2 | Details |
| CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
| CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
| Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
| 2-Acetylamino-1-{3’-O-[(4,4’-dimethoxy triphenyl)methyl]-a-L-threo furanosyl}-6-(N,N-diphenylcarbamoyloxy)-9H-purine | C45H40N6O8 | 325683-92-9 | Details |
| (S)-9-(2,3-Dihydroxypropyl)-2-amino-6-chloropurine | C8H10ClN5O2 | 885322-01-0 | Details |
| Methyl ? 3’-O-benzyl xyloriboside | C13H18O5 | 201014-45-1 | Details |
| 5’-Deoxy-5’-N-methylaminothymidine | Details |
| 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro guanosine | C13H14FN5O5 | 2389988-55-8 | Details |
| 5-Aza-3’-deoxycytidine | C8H12N4O4 | 455951-65-2 | Details |
| 2’-Deoxy-2’-fluoro-5-methyl-araobinocytidine ?5’-triphosphate triethyl ammonium salt（79570-62-0 free base) | C10H17FN3O13P3 | 79570-62-0 | Details |
| GSK778 hydrochloride | C30H33N5O3.ClH | 2863657-79-6 | Details |
| Milnacipran-d5 HCl | C15H17D5N2O.ClH | 2750534-79-1 | Details |
| 3’-O-Acetyl-2’-deoxyuridine | C11 H14 N2 O6 | 23197-88-8 | Details |
| N-Fmoc-aminohexyl P-methyl phosphonamidite | C28H41N2O3P | 128745-89-1 | Details |
| BPH-1358 free base | C32H28N6O2 | 801985-13-7 | Details |
| ASP1126 | C26H26ClF6NO5 | 1228580-11-7 | Details |
| Antitrypanosomal agent 2 | C17H13N5O3 | 475626-30-3 | Details |
| Antitumor agent-19 | C24H21ClF3N5O | 2379727-90-7 | Details |
| Autotaxin-IN-4 | C22H21N9O2 | 2156655-86-4 | Details |
| N2,N2-Dimethylamino-6-deamino adenosine | C12H17N5O4 | 105208-35-3 | Details |
| DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
| ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
| Flibanserin-d4 | C20H21F3N4O | 2122830-90-2 | Details |
| 2-C-methylene-myo-inositol oxide | C7H12O6 | 4068-87-5 | Details |
| BAY-7598 | C28H31N3O6 | 1816257-74-5 | Details |
| Aβ42-IN-1 free base | C29H26N4O2 | 2434633-17-5 | Details |
| Autotaxin-IN-5 | C30H29N9O2 | 2156655-99-9 | Details |
| Cardiotoxin Analog (CTX) IV (6-12) TFA | C48H70N10O7.C2HF3O2 | 2918768-05-3 | Details |
| H-PRO-HIS-CYS-LYS-ARG-MET-OH acetate | C31H54N12O7S2.C2H4O2 | 2918771-43-2 | Details |
| Lys-Bradykinin acetate(342-10-9 free base) | C56H85N17O12.4C2H4O2 | 84640-50-6 | Details |
| 2-Quinizarincarboxylic acid | C15H8O6 | 6416-55-3 | Details |
| (E)-5-Octadecene | C18H36 | 7206-21-5 | Details |
| Rifamycin S | C37H45NO12 | 13553-79-2 | Details |
| Patamostat HCl | C20H20N4O4S.ClH | 3031765-17-7 | Details |
| 5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole | C15H16BrN3O2 | 2863687-18-5 | Details |
| Antitumor agent-2 | C33H42N4O4 | 1351163-57-9 | Details |
| 1-Palmitoyl-2-succinyl-sn-glycerophosphorylcholine | C28H54NO10P | 89947-80-8 | Details |
| AHR antagonist 4 | C20H14F6N4O4 | 2242465-58-1 | Details |
| 1-PeCSO | C6H11NO3S | 3836-24-6 | Details |
| Antifungal agent 2 | C19H11Br2F3N4O2 | 2211060-61-4 | Details |
| Aniline-MPB-amino-C3-PBD | C42H46N8O6 | 2412923-79-4 | Details |
| anti-TB agent 1 | C23H19F3N4O3 | 2294013-78-6 | Details |
| Loteprednol Etabonate-d5 | C24H31ClO7 | 2026643-11-6 | Details |
| 2R-[(4,4’-Dimethoxy trityloxy)methyl]oxirane | C24H24O4 | 171406-50-1 | Details |
| 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine | C13H15N5O4 | 2389988-75-2 | Details |
| 20-HETE inhibitor-1 | C19H24N4O | 2472030-28-5 | Details |
| (R)-Monlunabant | 2765579-76-6 | Details |
| Tepotinib hydrochloride(1 : x) | C29H29ClN6O2 | 1103508-80-0 | Details |
| RR-src acetate | C64H106N22O21.C2H4O2 | 2986315-28-8 | Details |
| 1-[3’-O-[(4,4’-dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N6-benzoyladenine | C37H33N5O6 | 325683-88-3 | Details |
| BET-IN-6 | C22H20N2O6S | 2570470-39-0 | Details |
| (S)-(-)-MRJF22 | 2757301-90-7 | Details |
| 5-n-Heptyl-6-hydroxy-4,7-dioxobenzothiazole | C14H17NO3S | 611207-02-4 | Details |
| 10NH2-11F-Camptothecin | C20H16FN3O4 | 2873460-30-9 | Details |
| 2-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(beta-D-xylo furanosyl)purine | C14H19N5O5 | 2389988-30-9 | Details |
| 8-Benzyloxy-9-(b-D-xylofuranosyl)guanine | C17H19N5O6 | 2389988-19-4 | Details |
| TLR7 agonist 13 | C17H19N5O6 | 2389988-70-7 | Details |
| 5'-homocytidine | C10H15N3O5 | 55085-34-2 | Details |
| 2-Amino -7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-2,3,5-tri-O-actyl-xylofuranosyl)purine | C19H21N5O8 | 2389988-52-5 | Details |
| 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)purine | C13H15N5O5 | 2389988-53-6 | Details |
| 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro-xylo-guanosine | C13H14FN5O5 | 2389988-56-9 | Details |
| (1R)-Deruxtecan | C52H56FN9O13 | 2270986-87-1 | Details |
| (2E,9Z)-Octadeca-2,9-dienoic acid | C18H32O2 | 182369-03-5 | Details |
| CD235 | C26H20FN5O2 | 1627716-57-7 | Details |
| Compound 2389988-38-7 | C14H17N5O7 | 2389988-38-7 | Details |
| 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-2,5-di-O-acetyl-3-deoxy-3-fluoro-ribofuranosyl)purine | C17H18FN5O6 | 2389986-90-5 | Details |
| Alpha-5-Methyluridine | C10H14N2O6 | 3258-09-1 | Details |
| 2’-O-Phthalimidopropyl cytidine | C20H22N4O7 | 165381-50-0 | Details |
| 3’-Azido-3’-deoxyinosine | C10H11N7O4 | 946497-27-4 | Details |
| (αR)-Cyclopropaneacetamide-Exatecan | C29H28FN3O6 | 2414254-37-6 | Details |
| Compound 2389988-36-5 | C14H17N5O8 | 2389988-36-5 | Details |
| 2’-O-(2-Cyanoethoxy) ? (diisopropylamino)phosphino-3’-O-(4,4’-dimethoxy triphenyl)methyl-N2-isobutyryl-(R)-9-(2,3-dihydroxypropyl)-guanine | C42H52N7O7P | 182625-78-1 | Details |
| 1-alpha-D-(3-Meth oxynaphthalen-2-yl)-2’-deoxy riboside; (1S)-1,4-Anhy dro-2-deoxy-1-C-(3-methoxy)-naphthalenyl)-D-erythro-pentitol | C16H18O4 | 1502811-53-1 | Details |
| CP5V | C46H66Cl3N9O12S | 2509359-75-3 | Details |
| 1,2-Di-O-acetyl-3,5-di-O-benzyl-D-xylofuranose | C23H26O7 | 146986-45-0 | Details |
| 4,27-Dimethyl withaferin A | C30H42O6 | 1777780-95-6 | Details |
| (1-OH)-Exatecan | 2894780-53-9 | Details |
| (R)-FT709 | C23H22N4O7S | 2413991-75-8 | Details |
| 5-(2-Hydroxyethyl)cytidine | C11H17N3O6 | 137248-64-7 | Details |
| N4-Benzoyl-1-(6-O-DMTr-2,3-dideoxy-beta-D-erythro-hexopyranosyl)cytosine | C38H37N3O7 | 145594-00-9 | Details |
| 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy guanosine | C13H15N5O5 | 2389988-54-7 | Details |
| Chitinase-IN-2 hydrochloride | C20H22ClN5O2S | 2070014-83-2 | Details |
| 1-(2,3-Dideoxy-2,3-didehydro-a-D-erythro-hexo pyranosyl) cytosine | C10H13N3O4 | 199599-71-8 | Details |
| DC-5163 | C18H20ClN3OS | 897771-47-0 | Details |
| Product Total： Product Page： | ||||
| 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 | ||||